Cargando…
Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia
Chronic levodopa treatment leads to the appearance of dyskinesia in the majority of Parkinson’s disease patients. Neurovascular dysregulation in putaminal and pallidal regions is thought to be an underlying feature of this complication of treatment. We used microPET to study unilaterally lesioned 6-...
Autores principales: | Lerner, Renata P., Francardo, Veronica, Fujita, Koji, Bimpisidis, Zisis, Jourdain, Vincent A., Tang, Chris C., Dewey, Stephen L., Chaly, Thomas, Cenci, M. Angela, Eidelberg, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700135/ https://www.ncbi.nlm.nih.gov/pubmed/29167476 http://dx.doi.org/10.1038/s41598-017-16228-1 |
Ejemplares similares
-
Radiation Absorbed Dose to the Basal Ganglia from Dopamine Transporter Radioligand (18)F-FPCIT
por: Robeson, William, et al.
Publicado: (2014) -
Basal Ganglia Circuits Underlying the Pathophysiology of Levodopa-Induced Dyskinesia
por: Barroso-Chinea, Pedro, et al.
Publicado: (2010) -
Lesions in basal ganglia in a patient with involuntary movements as a first sign of diabetes – case report and review of the literature
por: Bekiesińska-Figatowska, Monika, et al.
Publicado: (2010) -
Assessment of abnormal involuntary movements in psychiatric patients.
por: Jaitpal, Varun, et al.
Publicado: (2022) -
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses
por: Simola, Nicola, et al.
Publicado: (2013)